[Zidovudine in prevention of HIV transmission by the infected mother to her child].
The effectiveness of a zidovudine prophylaxis to decrease vertical HIV transmission was tested in a multi-centre (59 clinics in the USA and France), randomised, placebo-controlled study. The mother was given zidovudine orally from the 14th gestational week and intravenously during delivery. The child was treated orally for the first 6 weeks of life. This prophylactic treatment resulted in a significant reduction of vertical HIV transmission from 26 to 8%. Although there are still some open questions, especially concerning the long-term consequences for the child, the Swiss Associations of Gynaecology and Obstetrics and of Paediatrics recommend using zidovudine for prophylaxis in the routine care of HIV-infected pregnant women.